Latest Global Expansion News

SenSen Networks has reported its first full year of positive operating cash flow, driven by strong growth in its Smart Cities segment and strategic cost reductions.

ClearVue Technologies initiates a thorough expenditure review and announces a key board resignation as it aims to sharpen its focus on product innovation and global expansion.

Pacific Edge reports steady demand for its Cxbladder cancer diagnostic tests despite losing Medicare coverage and transitioning US customers to a new test. The company is advancing clinical evidence and a $21 million capital raise to support growth and regain coverage.

Tissue Repair Limited has secured major distribution partnerships in Australia, New Zealand, and Thailand for its TR Pro+® product line, marking a pivotal shift from development to commercialisation. The company is also scaling up manufacturing and advancing regulatory approvals to support its global expansion ambitions.

RooLife Group has agreed to sell its Australian digital marketing subsidiary CHOOSE Digital for $356,500, marking a strategic pivot towards high-margin international product sales.

HITIQ Limited is set to debut its PROTEQT concussion management system in the UK on August 4, 2025, uniquely integrating with NHS 111 telehealth services to offer free medical guidance. This launch marks HITIQ’s first international consumer market entry and a strategic step in its global expansion.

Spacetalk Ltd has raised $3 million through convertible notes from its largest shareholder and converted $1 million of secured debt, positioning the company for international growth and new product development.

Nanoveu Limited has raised A$2 million through a strategic placement to accelerate the commercialisation of its 16nm ECS-DoT chip and expand its EMASS modular AIoT platform, positioning the company for global growth.

Artrya Limited has secured a five-year, US$0.6 million contract with Tanner Health, marking its inaugural commercial revenue in the U.S. market for its AI-powered Salix Coronary Anatomy platform.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.

Kinatico Limited has reported a record FY25 revenue of $32.1 million, driven by a remarkable 54% increase in SaaS revenue and a cash-positive year despite significant technology investments.

Unith Ltd has raised $1.85 million through a strategic share placement to accelerate the growth of its AI-driven Digital Human platform and expand its global footprint. The capital injection aims to boost platform development, marketing, and partnerships across key regions including Europe, LATAM, MENA, and Australia.